The constituent fund aims to achieve long term capital growth in Hong Kong dollar terms through a portfolio consisting primarily of securities of companies based or operating principally in the People's Republic of China, Hong Kong, Macau or Taiwan ("Greater China Region") and the majority of these companies are listed on a stock exchange in Hong Kong or Taiwan.

Latest Fund Expense Ratio: 1.48%

Launch Date(dd/mm/yyyy): 13/08/2012

Unit Price: HKD 17.44

Fund Size: HKD 869.57M

China equities endured a highly volatile quar ter, outperforming global peers, amid fears triggered by the dual onslaught of the COVID-19 pandemic and the oil price. On the heels of a blockbuster year in 2019, investor sentiment was riding high in the first month of the year, buoyed by the optimism around the Phase I trade deal, but soon fell prey to concerns around the outbreak of COVID-19 later in January and the negative economic impact from the subsequent lockdowns and containment measures taken by the Chinese government, as well as various travel restrictions imposed by other countries. In March, the COVID-19 pandemic continued taking its toll on global economic activity as well as financial stability, which was further complicated by the slump in oil price precipitated by the breakdown in OPEC+ negotiations. Rates fell further and the U.S. dollar rose but with heightened volatility. While the situation of the novel coronavirus outbreak remains fluid and short term disruption on both domestic consumption and global supply chain unavoidable, we take comfort in Chinese government’s strong outbreak containment measures as well as proactive countercyclical economic policies to mitigate the negative impact on consumption and employment.